The placement of ADM's CFO on leave and the investigation into accounting practices raise concerns about financial transparency and potential restatements, which are negative for investor sentiment. The lowered EPS outlook and withdrawal of the nutrition segment forecast suggest operational challenges, which could further impact the stock negatively. Baird's downgrade and reduced price target reflect a bearish outlook from analysts, likely leading to a decrease in investor confidence and a short-term negative impact on the stock price.